Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Osiris Therapeutics, Inc.    OSIR   US68827R1086

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/15/2014 09/16/2014 09/17/2014 09/18/2014 09/19/2014 Date
12.73(c) 12.99(c) 13.29(c) 13.15(c) 13.25 Last
163 523 147 311 200 008 180 082 369 197 Volume
-1.85% +2.04% +2.31% -1.05% +0.76% Change
More quotes
Company
Osiris Therapeutics, Inc. is a stem cell company, which focuses on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular, orthopedic and wound healing markets.The company operates its business through two segments: Therapeutics and Biosurgery segment.The... 
Surperformance© rating of Osiris Therapeutics, Inc.
Trading Rating : - Investor Rating :
More about the company
Chart OSIRIS THERAPEUTICS, INC.
Duration : Period :
Osiris Therapeutics, Inc. Technical Analysis Chart | OSIR | US68827R1086 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 54,5 M
EBIT 2014 -3,74 M
Net income 2014 2,35 M
Debt 2014 -
Yield 2014 -
Sales 2015 82,5 M
EBIT 2015 6,70 M
Net income 2015 10,3 M
Debt 2015 -
Yield 2015 -
PER 2014 239,09
PER 2015 44,58
Capi. / Sales 2014 8,28x
Capi. / Sales 2015 5,47x
Capitalization 451 M
More Financials
Latest news on OSIRIS THERAPEUTICS, INC.
1d ago OSIRIS THERAPEUTICS : Presents at Joint Annual Meeting of the Eastern and New En..
2d ago OSIRIS THERAPEUTICS : Grafix® Randomized Controlled Clinical Trial Recognized as..
3d ago OSIRIS THERAPEUTICS : Rolls Out Supplement in Wounds
4d ago OSIRIS THERAPEUTICS : Grafix® Featured in Plenary Session Oral Presentation at t..
09/11 OSIRIS THERAPEUTICS : Grafix® Randomized Controlled Clinical Trial Recognized as..
08/20 OSIRIS THERAPEUTICS : EQUITY ALERT: Rosen Law Firm Announces Investigation of Se..
08/14 OSIRIS THERAPEUTICS : EQUITY ALERT: Rosen Law Firm Announces Investigation of Se..
08/11 OSIRIS THERAPEUTICS : Management's Discussion and Analysis of Financial Conditio..
08/07 OSIRIS THERAPEUTICS : Announces Second Quarter 2014 Financial Results: Revenue U..
08/07 OSIRIS THERAPEUTICS : Results of Operations and Financial Condition, Financial S..
07/30 OSIRIS THERAPEUTICS' : Grafix Manuscript Available Online
07/27 OSIRIS THERAPEUTICS : Bolsters Its Grafix Product Portfolio
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
Osiris Therapeutics, Inc. : Income Statement Evolution
More Financials
EPS Revisions
Osiris Therapeutics, Inc. : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF